Secarna Pharmaceuticals GmbH & Co. KG
Industry
- Biotechnology
- Antisense, Oligonucleotides
- Drug Discovery Technologies
- Pharmaceuticals
Latest on Secarna Pharmaceuticals GmbH & Co. KG
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Quiver, QurAlis To Combine Tech Platfor
Founded in 2015, Secarna Pharmaceuticals entered the antisense drug discovery and development space with the goal of addressing high unmet medical needs using a never-before-seen artificial intellig
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cycle Offers $466m For Vanda, Which Tur
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets Xilio’s Phase I Cancer Drug